Sorafenib and 2-Deoxyglucose: The Future of Hepatocellular Carcinoma Therapy

Sorafenib and 2-Deoxyglucose: The Future of Hepatocellular Carcinoma Therapy

Bibliographic Details
Main Author: Reyes, Ryan
Language:English
Published: The Ohio State University / OhioLINK 2016
Subjects:
Therapy
Medicine
Molecular Biology
Sorafenib
2-Deoxyglucose
2DG
Combination therapy
Synergy
Sorafenib Resistance
Liver Cancer
HCC
Cell cycle arrest
Proliferation
Growth
Hepatocellular Carinoma
Online Access:http://rave.ohiolink.edu/etdc/view?acc_num=osu1461275086

Internet

http://rave.ohiolink.edu/etdc/view?acc_num=osu1461275086

Similar Items